Chemotherapy
Microbiology
Possible Role of sarA in Dehydroepiandrosterone-Mediated Increase in Staphylococcus aureus Resistance to VancomycinPlotkin B.J.a · Konaklieva M.baDepartment of Microbiology and Immunology, Midwestern University, Downers Grove, Ill., bDepartment of Chemistry, American University, Washington D.C., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: November 29, 2005
Accepted: January 31, 2006
Published online: March 14, 2007
Issue release date: April 2007
Number of Print Pages: 4
Number of Figures: 2
Number of Tables: 0
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Abstract
Background: Dehydroepiandrosterone (DHEA), a steroid present throughout life, can induce an increase in resistance to vancomycin in methicillin-sensitive and methicillin-resistant clinical isolates of Staphylococcus aureus. Methods: The in vitro effect of DHEA on vancomycin killing of S. aureus with mutations in sarA and/or agr was determined by standard microtiter protocols and time to kill determinations. Results: Of the isolates tested, the strain with a deletion in sarAderived from a DHEA- responsive parent was not protected from vancomycin killing by DHEA. However, DHEA significantly (p < 0.01) slowed the rate of vancomycin killing of sarA–. Conclusion: These data indicate that sarA may play a role in DHEA-mediated protection from vancomycin killing of S. aureus.
© 2007 S. Karger AG, Basel
Related Articles:
References
- Plotkin B, Morejon A, Laddaga R, Viselli S, Thijo J, Schreckenberger P: Induction of increased resistance to vancomycin in Staphylococcus aureus clinical isolates (MSSA, MRSA) by dehydroepiandosterone (DHEA). Lett Appl Microbiol 2005;40:249–254.
- Chan P, Foster S: Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J Bacteriol 1998;180:6232–6241.
- Piriz-Duran S, Kayser F, Berger-Bachi B: Impact of sar and agr on methicillin resistance in Staphylococcus aureus. FEMS Microbiol Lett 1996;141:255–260.
-
National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Testing for Bacteria That Grew Aerobically: Approved Standard. Wayne, National Committee for Clinical Laboratory Standards, 1997.
-
National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing: Eighth Informational Supplement. Wayne, National Committee for Clinical Laboratory Standards, 1998.
- Canton E, Ramon M, Jimenez M, Martinez J: Killing kinetics of four quinolones against gram-positive cocci. Chemotherapy 1993;39:394–399.
- May J, Shannon K, King A, French G: Glycopeptide tolerance in Staphylococcus aureus. J Antimicrob Chemother 1998;42:189–197.
- Cordwell S, Larsen M, Cole R, Walsh B: Comparative proteomics of Staphylococcus aureus and the response of methicillin-resistant and methicillin-sensitive strains to Triton X-100. Microbiology 2002;148:2765–2781.
- Yotis W, Fitzgerald T: Hormonally induced alterations in Staphylococcus aureus. Ann NY Acad Sci 1974;236:187–202.
Article / Publication Details
Received: November 29, 2005
Accepted: January 31, 2006
Published online: March 14, 2007
Issue release date: April 2007
Number of Print Pages: 4
Number of Figures: 2
Number of Tables: 0
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission